Clinical Updates

Interim results from an early stage trial of Pharmacyclics Inc’s experimental blood cancer drug show the number of leukemia patients… »   

Bayer expects to see falling profit margins in drugs and plastics as the euro debt crisis sends tremors through economy,… »   

A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on… »   

The health secretary overruled government scientists and refused to bring the controversial morning-after pill from behind the pharmacy counter and… »   

The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of… »   

French drugmaker Sanofi said a late-stage study of its lixisenatide drug in combination with Lantus insulin showed a significant improvement… »   

Bristol-Myers Squibb Co and Johnson & Johnson plan to jointly develop experimental treatments for hepatitis C in a market worth… »   

Three leading senators are inquiring into drugmaker Pfizer Inc’s efforts to limit the sale of generic versions of its Lipitor… »   

Just 24 hours after Lisa Rek sang at her niece’s wedding, her husband Brad was driving her to a local… »   

Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate… »   

Lipitor, the popular cholesterol-lowering drug, loses its patent Wednesday, paving the way for cheaper generic versions.

“For generic drugs, they… »   

As cholesterol fighter Lipitor goes generic, its maker Pfizer Inc is hoping to hold onto perhaps a third of the… »   

A study to be published in the online journal mBio® on November 29 shows that adding antibiotics to swine feed… »   

Academic and government leaders announced today the establishment of a major new research institute at The University of Texas MD… »   

Researchers from Mount Sinai School of Medicine, have identified the pattern of cell signaling induced by antipsychotic drugs in a… »